UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 2
February-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2102101


Registration ID:
305673

Page Number

856-868

Share This Article


Jetir RMS

Title

CLINICAL APPROVED LIPOSOMAL FORMULATIONS: A OVER VIEW

Abstract

Liposomes are vesicular colloidal carrier system composed of phospholipids bilayer encapsulate aqueous compartments. Since 1960’s liposomes used as therapeutic tools for the delivery of bioactives.Hence number of liposomal formulations available in the market as compare to other carrier system such as nanoparticles,dendrimers etc. The structure and composition of liposomes has a great impact on their properties like biocompatibility,bioactive payload, immuo neutralization,absence of cytotoxicity and hemolytic toxicity. As a result of their unique liposomes are suitable for a wide range of biomedical and industrial applications.The paper gives a concise review of liposomes formulation physico-chemical properties and their clinical application in vaccination, tumor targeting, immunomodulation, topical delivery of bioactives for skin care,gene and antisense therapy. The goal of this review is to provide a short outline of the properties of liposomes and market research analysis of liposomes clinical approved products.

Key Words

Drug delivery; Liposome; Target ligand

Cite This Article

"CLINICAL APPROVED LIPOSOMAL FORMULATIONS: A OVER VIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 2, page no.856-868, February-2021, Available :http://www.jetir.org/papers/JETIR2102101.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"CLINICAL APPROVED LIPOSOMAL FORMULATIONS: A OVER VIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 2, page no. pp856-868, February-2021, Available at : http://www.jetir.org/papers/JETIR2102101.pdf

Publication Details

Published Paper ID: JETIR2102101
Registration ID: 305673
Published In: Volume 8 | Issue 2 | Year February-2021
DOI (Digital Object Identifier):
Page No: 856-868
Country: BHOPAL, MADHYA PRADESH, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0003165

Print This Page

Current Call For Paper

Jetir RMS